Bio-Rad Outranks Other Protein Visualization Product Suppliers By Far
by Anonymous

ARLINGTON, VA – January 18, 2002 – Bio-Rad Laboratories is the company that scientists most closely associate with products for protein visualization. Pierce Chemical, Amersham Biosciences, Sigma and Molecular Probes rounded out the top five. This finding is just one of the many insights derived from “The Tools & Techniques of Protein Science: Catalyzing the Future of Proteomics,” a market research series based on eight separate surveys of scientists actively engaged in protein research. The series, which investigates every facet of the protein research market, was recently published by BioInformatics LLC, a leading provider of market research to the biotechnology industry. The eight titles in the series can be purchased separately or as a set and have yielded an enormous amount of data with important implications for the market’s suppliers.

“Protein Visualization,” the fourth of the eight reports, explores the issues faced by life scientists when visualizing proteins and specifically examines the products and technologies used in protein staining and/or labeling, detecting and imaging. According to Tamara Zemlo, PhD, Director of Scientific & Medical Communications for The Science Advisory Board, “the market for imaging systems is dominated by the needs of core and shared facilities, rather than the individual laboratory. This finding implies that purchasing patterns could possibly be influenced by competing research priorities.”

Findings in this report indicate that high image resolution is the number one factor that would influence a respondent’s lab to purchase one protein imaging system over another. Additionally, while respondents use different types of stains and labels depending upon the procedure they perform, the primary reason they select one particular stain over another is its ability to detect low quantities of proteins. Zemlo believes these findings to be significant because “as researchers’ expectations for obtaining high-quality imaging data increase, companies’ product lines will have to evolve to allow for the development of more powerful imaging instrumentation capable of increased sensitivity and finer resolution.”

More than a dozen industry leaders are already using this report and others in the series to assess their market position, create more effective marketing strategies and develop new products precisely tailored to the needs of the market.

ABOUT BIOINFORMATICS LLC

BioInformatics LLC (http://www.gene2drug.com) is a market research firm located in Arlington, Virginia. BioInformatics supports marketing, sales and R&D executives in the life science, medical device and pharmaceutical industries through published research reports, custom research and consulting. BioInformatics sponsors The Science Advisory Board (http://www.scienceboard.net), an online panel of more than 6,000 scientists, physicians and other biomedical customers from 62 countries who participate in surveys that address emerging technologies, test customer reactions to new product concepts, measure brand awareness and assess advertising effectiveness.

FOR A COMPLIMENTARY EXECUTIVE SUMMARY PLEASE VISIT HTTP://WWW.GENE2DRUG.COM OR CONTACT:

Alyssa Martin
BioInformatics LLC
2111 Wilson Blvd. Suite 1200
Arlington, VA 22201
703.525.3872 x358 phone
703.522.3685 fax
a.martin@gene2drug.com




This article courtesy of http://www.allwheyprotein.com. You may freely reprint this article on your website or in your newsletter provided this courtesy notice and the author name and URL remain intact.

Submit Your Article